Nanobiotix Files July 2025 6-K Report
Ticker: NBTX · Form: 6-K · Filed: Jul 11, 2025 · CIK: 1760854
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Nanobiotix filed its July 6-K, standard foreign private issuer update.
AI Summary
Nanobiotix S.A. filed a Form 6-K on July 11, 2025, reporting for the month of July 2025. The company, a foreign private issuer, is based in Paris, France, and operates in the pharmaceutical preparations sector. This filing is made pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates for Nanobiotix S.A. as a foreign private issuer, informing investors about their ongoing compliance and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Nanobiotix S.A. (company) — Filer of the report
- Paris, France (location) — Company's principal executive office
- July 2025 (date) — Reporting period
- July 11, 2025 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
What is Nanobiotix S.A.'s primary business sector?
Nanobiotix S.A. is in the Pharmaceutical Preparations sector, with SIC code 2834.
Where is Nanobiotix S.A. headquartered?
Nanobiotix S.A. is headquartered at 60 Rue de Wattignies, 75012 Paris, France.
What is the SEC file number for Nanobiotix S.A.?
The SEC file number for Nanobiotix S.A. is 001-39777.
Does Nanobiotix S.A. file annual reports under Form 20-F?
Yes, Nanobiotix S.A. indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 11, 2025 regarding Nanobiotix S.A. (NBTX).